The ATLAS drug-eluting coronary stent is INVAMED's cobalt-chromium platform intended for use in percutaneous coronary intervention procedures, combining a laser-cut metal scaffold with a sirolimus drug coating. Designed for interventional cardiology teams managing coronary artery disease, the ATLAS platform reflects a design approach that pairs thin-strut mechanical support with localized anti-proliferative drug delivery. This overview summarizes the platform's design features as described on invamed.com; final device selection remains subject to physician judgment and the official Instructions for Use.
What Is the ATLAS Drug-Eluting Stent Platform?
ATLAS is built on a cobalt-chromium L605 alloy frame, a material widely used in contemporary drug-eluting stent design for its combination of strength and thin-strut capability. The stent body is laser-cut from a single tube of alloy, a manufacturing approach intended to produce a consistent, precisely patterned mesh structure.
- Cobalt-chromium L605 alloy frame
- Laser-cut construction for structural precision
- Open-cell design intended to support flexibility and deliverability
- Designed to serve as a mechanical scaffold supporting the treated coronary artery segment
What Are the Key Structural Design Features?
The ATLAS platform is engineered around several specific structural characteristics:
- Strut thickness: Approximately 60 micron struts, reflecting the thin-strut design capability associated with cobalt-chromium alloys, intended to support vessel wall coverage and conformability.
- Open-cell geometry: Intended to enhance flexibility for navigating tortuous coronary anatomy and to support side-branch accessibility.
- Radiopaque markers: Platinum-iridium markers positioned at the stent extremities to assist physicians with precise visualization and positioning under fluoroscopic guidance during deployment.
These structural elements are intended to work together to balance radial strength, flexibility, and deliverability during PCI procedures.
What Is the Drug-Elution Component?
The ATLAS drug-eluting stent is coated with a sirolimus formulation at a concentration of 1 µg/mm². Sirolimus is an anti-proliferative agent designed to be released in a controlled manner into the surrounding vessel wall tissue following implantation. This localized drug delivery approach is intended to address the biological healing response that can otherwise lead to excessive tissue growth within the stented segment, a process associated with in-stent restenosis.
What Clinical Considerations Apply?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Frequently Asked Questions
What alloy is used in the ATLAS drug-eluting stent?
The ATLAS drug-eluting coronary stent uses a cobalt-chromium L605 alloy frame, a material selected for its combination of radial strength and compatibility with thin-strut, laser-cut manufacturing.
What is the purpose of the platinum-iridium markers?
The radiopaque platinum-iridium markers at the stent extremities are designed to help the implanting physician visualize the exact stent position under fluoroscopy during the deployment procedure, supporting accurate placement.
Is the ATLAS drug-eluting stent available in multiple sizes?
Coronary stent platforms are typically manufactured in a range of diameters and lengths to accommodate different vessel anatomies. Clinicians should consult the official product catalog and Instructions for Use, or contact INVAMED directly, for specific size availability.
Related INVAMED Resources
- Coronary Artery Disease & Cardiac Interventions
- Atlas Coronary Stent System Stainless Steel
- Contact INVAMED for Product Information
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.